High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 7, 2020

Primary Completion Date

April 30, 2025

Study Completion Date

December 31, 2026

Conditions

Allogeneic Hematopoietic Stem Cell Transplantation Recipient

Interventions

DIETARY_SUPPLEMENT

Vitamin A Compound

Given PO or enterally

OTHER

Best Practice

Receive usual care

Trial Locations (1)

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors

lead

Ohio State University Comprehensive Cancer Center

OTHER